How the perception of risks and benefits influence cancer clinical trial withdrawal outcomes How the perception of risks and benefits influence cancer clinical trial withdrawal outcomes A new study from the School of Nursing examines the association between patients’ perceived benefits and burdens of research participation and withdrawal.
Another Crispr first: New treatment wipes out teen’s cancer Penn In the News The Washington Post Another Crispr first: New treatment wipes out teen’s cancer Bruce Levine of the Perelman School of Medicine says that the latest results of Crispr gene editing in a cancer patient have showcased the best possible clinical outcome thus far. CRISPR gene-editing may boost cancer immunotherapy, new study finds Penn In the News NPR CRISPR gene-editing may boost cancer immunotherapy, new study finds Carl June of the Perelman School of Medicine says that off-the-shelf CAR-T cell therapies using CRISPR would be a game-changer. Study shows promise of new anti-KRAS drug for pancreatic cancer Study shows promise of new anti-KRAS drug for pancreatic cancer A small molecule inhibitor that attacks the difficult cancer-causing gene mutation KRAS successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer. HPV-related cancers are on the rise in men HPV-related cancers are on the rise in men Recent CDC data show that roughly four of every 10 cases of HPV-induced cancer now occur in men. Penn Medicine research has found that differences in levels of a particular HPV protein may inform treatment. CAR T cell therapy reaches beyond cancer CAR T cell therapy reaches beyond cancer Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies. Dogs may hold key to treating cancer in humans Penn In the News CBS News Dogs may hold key to treating cancer in humans A study by Nicola Mason of the School of Veterinary Medicine and colleagues found that an experimental immunotherapy treatment using genetically modified listeria could extend the life expectancy of dogs with cancer. Home health care—a crucial edge for the future of medicine (On homepage) Renee Jones helps Valerie Simon toward her ultimate recovery goal after a hip replacement: being able to walk to the corner store and cross the street before the light turns red, using a cane rather than a walker. Home health care—a crucial edge for the future of medicine Home care has long been a part of health care, but it was the COVID-19 pandemic that led Penn Medicine to rethink who needed to be in the hospital. Why cancers caused by BRCA mutations recur Why cancers caused by BRCA mutations recur Findings from Penn Medicine uncover possible drivers of recurrent breast and ovarian cancers among women carrying high-risk genetic mutations, pointing to methods to more effectively treat disease. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Load More
CRISPR gene-editing may boost cancer immunotherapy, new study finds Penn In the News NPR CRISPR gene-editing may boost cancer immunotherapy, new study finds Carl June of the Perelman School of Medicine says that off-the-shelf CAR-T cell therapies using CRISPR would be a game-changer. Study shows promise of new anti-KRAS drug for pancreatic cancer Study shows promise of new anti-KRAS drug for pancreatic cancer A small molecule inhibitor that attacks the difficult cancer-causing gene mutation KRAS successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer. HPV-related cancers are on the rise in men HPV-related cancers are on the rise in men Recent CDC data show that roughly four of every 10 cases of HPV-induced cancer now occur in men. Penn Medicine research has found that differences in levels of a particular HPV protein may inform treatment. CAR T cell therapy reaches beyond cancer CAR T cell therapy reaches beyond cancer Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies. Dogs may hold key to treating cancer in humans Penn In the News CBS News Dogs may hold key to treating cancer in humans A study by Nicola Mason of the School of Veterinary Medicine and colleagues found that an experimental immunotherapy treatment using genetically modified listeria could extend the life expectancy of dogs with cancer. Home health care—a crucial edge for the future of medicine (On homepage) Renee Jones helps Valerie Simon toward her ultimate recovery goal after a hip replacement: being able to walk to the corner store and cross the street before the light turns red, using a cane rather than a walker. Home health care—a crucial edge for the future of medicine Home care has long been a part of health care, but it was the COVID-19 pandemic that led Penn Medicine to rethink who needed to be in the hospital. Why cancers caused by BRCA mutations recur Why cancers caused by BRCA mutations recur Findings from Penn Medicine uncover possible drivers of recurrent breast and ovarian cancers among women carrying high-risk genetic mutations, pointing to methods to more effectively treat disease. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Load More
Study shows promise of new anti-KRAS drug for pancreatic cancer Study shows promise of new anti-KRAS drug for pancreatic cancer A small molecule inhibitor that attacks the difficult cancer-causing gene mutation KRAS successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer.
HPV-related cancers are on the rise in men HPV-related cancers are on the rise in men Recent CDC data show that roughly four of every 10 cases of HPV-induced cancer now occur in men. Penn Medicine research has found that differences in levels of a particular HPV protein may inform treatment.
CAR T cell therapy reaches beyond cancer CAR T cell therapy reaches beyond cancer Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies.
Dogs may hold key to treating cancer in humans Penn In the News CBS News Dogs may hold key to treating cancer in humans A study by Nicola Mason of the School of Veterinary Medicine and colleagues found that an experimental immunotherapy treatment using genetically modified listeria could extend the life expectancy of dogs with cancer. Home health care—a crucial edge for the future of medicine (On homepage) Renee Jones helps Valerie Simon toward her ultimate recovery goal after a hip replacement: being able to walk to the corner store and cross the street before the light turns red, using a cane rather than a walker. Home health care—a crucial edge for the future of medicine Home care has long been a part of health care, but it was the COVID-19 pandemic that led Penn Medicine to rethink who needed to be in the hospital. Why cancers caused by BRCA mutations recur Why cancers caused by BRCA mutations recur Findings from Penn Medicine uncover possible drivers of recurrent breast and ovarian cancers among women carrying high-risk genetic mutations, pointing to methods to more effectively treat disease. CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies. Load More
Home health care—a crucial edge for the future of medicine (On homepage) Renee Jones helps Valerie Simon toward her ultimate recovery goal after a hip replacement: being able to walk to the corner store and cross the street before the light turns red, using a cane rather than a walker. Home health care—a crucial edge for the future of medicine Home care has long been a part of health care, but it was the COVID-19 pandemic that led Penn Medicine to rethink who needed to be in the hospital.
Why cancers caused by BRCA mutations recur Why cancers caused by BRCA mutations recur Findings from Penn Medicine uncover possible drivers of recurrent breast and ovarian cancers among women carrying high-risk genetic mutations, pointing to methods to more effectively treat disease.
CRISPR cancer trial success paves the way for personalized treatments Penn In the News Nature CRISPR cancer trial success paves the way for personalized treatments Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies.